drugset / Trial / NCT01776671
Once Daily Gabapentin in the Treatment of Post Amputation Pain
NaSingle-groupOpen-labelTreatment
Summary
Phantom limb pain (PLP) is a common disorder reported by the patients who undergo amputation. Even though the cause of PLP remains unclear, Gabapentin has been widely used. The purpose of this study is to evaluate the accuracy and efficacy achieved in using of extended release Gabapentin. Reducing the incidence of chronic post-amputation pain and improving clinical outcomes postoperatively.
Timeline
- Start
- 2013-02
- Primary completion
- 2018-11
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | 1800 mg | — |
Indications
No indication recorded.